Remyelination can be extensive in multiple sclerosis despite a long disease course - PubMed (original) (raw)
Remyelination can be extensive in multiple sclerosis despite a long disease course
R Patani et al. Neuropathol Appl Neurobiol. 2007 Jun.
Abstract
Experimental studies using models of multiple sclerosis (MS) indicate that rapid and extensive remyelination of inflammatory demyelinated lesions is not only possible, but is the normal situation. The presence of completely remyelinated MS lesions has been noted in numerous studies and routine limited sampling of post mortem MS material suggests that remyelination may be extensive in the early stages but eventually fails. However, visual macroscopic guided sampling tends to be biased towards chronic demyelinated lesions. Here we have extensively sampled cerebral tissue from two MS cases to investigate the true extent of remyelination. Sections were cut from 185 cerebral tissue blocks and stained with haematoxylin and eosin (H&E), luxol fast blue and cresyl fast violet (LFB/CFV) and anti-myelin oligodendrocyte glycoprotein, human leucocyte antigen-DR (HLA-DR) and 200 kDa neurofilament protein antibodies. Demyelinated areas were identified in 141 blocks, comprising both white matter (WMLs) and/or grey matter lesions. In total, 168 WMLs were identified, 22% of which were shadow plaques, 73% were partially remyelinated and only 5% were completely demyelinated. The average extent of lesion remyelination for all WMLs investigated was 47%. Increased density of HLA-DR(+) macrophages and microglia at the lesion border correlated significantly with more extensive remyelination. Results from this study of two patients with long standing disease suggest that remyelination in MS may be more extensive than previously thought.
Similar articles
- Remyelination capacity of the MS brain decreases with disease chronicity.
Goldschmidt T, Antel J, König FB, Brück W, Kuhlmann T. Goldschmidt T, et al. Neurology. 2009 Jun 2;72(22):1914-21. doi: 10.1212/WNL.0b013e3181a8260a. Neurology. 2009. PMID: 19487649 - Remyelination is extensive in a subset of multiple sclerosis patients.
Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H. Patrikios P, et al. Brain. 2006 Dec;129(Pt 12):3165-72. doi: 10.1093/brain/awl217. Epub 2006 Aug 18. Brain. 2006. PMID: 16921173 - Demyelination versus remyelination in progressive multiple sclerosis.
Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H. Bramow S, et al. Brain. 2010 Oct;133(10):2983-98. doi: 10.1093/brain/awq250. Epub 2010 Sep 20. Brain. 2010. PMID: 20855416 - Gender differences in the histopathology of MS?
Kuhlmann T, Goldschmidt T, Antel J, Wegner C, König F, Metz I, Brück W. Kuhlmann T, et al. J Neurol Sci. 2009 Nov 15;286(1-2):86-91. doi: 10.1016/j.jns.2009.07.014. Epub 2009 Aug 11. J Neurol Sci. 2009. PMID: 19674757 Review. - The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
Lassmann H. Lassmann H. Neuroimaging Clin N Am. 2008 Nov;18(4):563-76, ix. doi: 10.1016/j.nic.2008.06.005. Neuroimaging Clin N Am. 2008. PMID: 19068402 Review.
Cited by
- DOR activation in mature oligodendrocytes regulates α-ketoglutarate metabolism leading to enhanced remyelination in aged mice.
Huang G, Li Z, Liu X, Guan M, Zhou S, Zhong X, Zheng T, Xin D, Gu X, Mu D, Guo Y, Zhang L, Zhang L, Lu QR, He X. Huang G, et al. Nat Neurosci. 2024 Sep 12. doi: 10.1038/s41593-024-01754-9. Online ahead of print. Nat Neurosci. 2024. PMID: 39266660 - Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions.
Wilkins JM, Mangalaparthi KK, Netzel BC, Sherman WA, Guo Y, Kalinowska-Lyszczarz A, Pandey A, Lucchinetti CF. Wilkins JM, et al. Front Mol Neurosci. 2024 Aug 21;17:1448215. doi: 10.3389/fnmol.2024.1448215. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39234409 Free PMC article. - Microglia and Multiple Sclerosis.
Hammond BP, Panda SP, Kaushik DK, Plemel JR. Hammond BP, et al. Adv Neurobiol. 2024;37:445-456. doi: 10.1007/978-3-031-55529-9_25. Adv Neurobiol. 2024. PMID: 39207707 Review. - Loss of miR-145 promotes remyelination and functional recovery in a model of chronic central demyelination.
Kornfeld SF, Cummings SE, Yaworski R, De Repentigny Y, Gagnon S, Zandee S, Fathi S, Prat A, Kothary R. Kornfeld SF, et al. Commun Biol. 2024 Jul 4;7(1):813. doi: 10.1038/s42003-024-06513-x. Commun Biol. 2024. PMID: 38965401 Free PMC article. - Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
Lazzarotto A, Hamzaoui M, Tonietto M, Dubessy AL, Khalil M, Pirpamer L, Ropele S, Enzinger C, Battaglini M, Stromillo ML, De Stefano N, Filippi M, Rocca MA, Gallo P, Gasperini C, Stankoff B, Bodini B; MAGNIMS Study Group. Lazzarotto A, et al. Brain. 2024 Apr 4;147(4):1331-1343. doi: 10.1093/brain/awae024. Brain. 2024. PMID: 38267729 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials